반응식
[N:1]1[C:10]2[C:5](=[CH:6][CH:7]=[C:8]([CH:11]=O)[CH:9]=2)[CH:4]=[CH:3][CH:2]=1.N1C=CC=CC=1C1C=C[C:22]([CH:23]=[O:24])=CC=1>>[N:1]1[C:10]2[C:5](=[CH:6][CH:7]=[C:8](/[CH:11]=[CH:22]/[CH:23]=[O:24])[CH:9]=2)[CH:4]=[CH:3][CH:2]=1참가 물질
3
실험 절차
The title compound was prepared by a procedure analogous to Reference Example 31 by substituting 7-quinolinecarboxaldehyde (prepared as described in J. Med. Chem. 1993, 36, 3308) for the 4-(2-pyridinyl)-benzaldehyde of Reference Example 31. MS 184 (M+H)+.
출처 및 근거
- ORD 기록
- ord-13bd3e640ffe45808037060db7d2129b
- 출처 데이터셋
- uspto-grants-2004_03
- 특허 번호
- US06713455B2
연결된 노트
불러오는 중…